These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33350934)

  • 41. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
    Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
    J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.
    Han HJ; Kuwae A; Abe A; Arakawa Y; Kamachi K
    PLoS One; 2011 Mar; 6(3):e17797. PubMed ID: 21423776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bordetella pertussis evolution in the (functional) genomics era.
    Belcher T; Preston A
    Pathog Dis; 2015 Nov; 73(8):ftv064. PubMed ID: 26297914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization.
    Caro V; Hot D; Guigon G; Hubans C; Arrivé M; Soubigou G; Renauld-Mongénie G; Antoine R; Locht C; Lemoine Y; Guiso N
    Microbes Infect; 2006 Jul; 8(8):2228-35. PubMed ID: 16787756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic.
    Safarchi A; Octavia S; Wu SZ; Kaur S; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Keil AD; Lan R
    J Infect; 2016 Apr; 72(4):468-77. PubMed ID: 26826518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigenic and genetic characterization of Bordetella pertussis recovered from Quebec, Canada, 2002-2014: detection of a genetic shift.
    Shuel M; Lefebvre B; Whyte K; Hayden K; De Serres G; Brousseau N; Tsang RS
    Can J Microbiol; 2016 May; 62(5):437-41. PubMed ID: 26910633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
    Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
    J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
    Bailon H; León-Janampa N; Padilla C; Hozbor D
    BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetic evolution under vaccine pressure: the Bordetella pertussis model].
    Simondon F; Guiso N
    Bull Soc Pathol Exot; 2000 Jul; 93(3):202-5. PubMed ID: 11030058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors contributing to pertussis resurgence.
    He Q; Mertsola J
    Future Microbiol; 2008 Jun; 3(3):329-39. PubMed ID: 18505398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.
    Marchand-Austin A; Tsang RSW; Guthrie JL; Ma JH; Lim GH; Crowcroft NS; Deeks SL; Farrell DJ; Jamieson FB
    J Clin Microbiol; 2017 May; 55(5):1446-1453. PubMed ID: 28228490
    [No Abstract]   [Full Text] [Related]  

  • 52. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?
    Godfroid F; Denoël P; Poolman J
    Expert Rev Vaccines; 2005 Oct; 4(5):757-78. PubMed ID: 16221076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran.
    Sadeghpour Heravi F; Nikbin VS; Nakhost Lotfi M; Badiri P; Jannesar Ahmadi N; Zahraei SM; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1893-1900. PubMed ID: 30094521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The epidemic of erythromycin-resistant
    Yao K; Deng J; Ma X; Dai W; Chen Q; Zhou K; Ye J; Shi W; Wang H; Li D; Wang H; Wang J; Zhang J; Wu D; Xie G; Shen K; Zheng Y; Yang Y
    Expert Rev Vaccines; 2020 Nov; 19(11):1093-1099. PubMed ID: 33034224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pertussis vaccines: state-of-the-art and future trends.
    Tefon BE; Özcengiz E; Özcengiz G
    Curr Top Med Chem; 2013; 13(20):2581-96. PubMed ID: 24066885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving.
    Sealey KL; Harris SR; Fry NK; Hurst LD; Gorringe AR; Parkhill J; Preston A
    J Infect Dis; 2015 Jul; 212(2):294-301. PubMed ID: 25489002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994.
    Peppler MS; Kuny S; Nevesinjac A; Rogers C; de Moissac YR; Knowles K; Lorange M; De Serres G; Talbot J
    J Clin Microbiol; 2003 Jul; 41(7):3344-7. PubMed ID: 12843089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines.
    van Loo IHM; Mooi FR
    Microbiology (Reading); 2002 Jul; 148(Pt 7):2011-2018. PubMed ID: 12101289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of Bordetella pertussis strains which do not produce virulence factors in the epidemiology of pertussis.
    Polak M; Lutyńska A
    Postepy Hig Med Dosw (Online); 2017 May; 71(0):367-379. PubMed ID: 28513461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the
    Wong TY; Hall JM; Nowak ES; Boehm DT; Gonyar LA; Hewlett EL; Eby JC; Barbier M; Damron FH
    mSphere; 2019 Apr; 4(2):. PubMed ID: 30996109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.